Home » Roche Receives CE Mark for Elecsys Cancer Test
Roche Receives CE Mark for Elecsys Cancer Test
Roche has received CE mark certification for its Elecsys anti-p53 immunoassay, a test used to diagnose various types of cancer.
The Elecsys test is used for the in vitro quantitative determination of anti-p53 antibodies in patients to aid physicians in diagnosis of esophageal cancer, bowel cancer and breast cancer.
Screening for anti-p53 antibodies can help to diagnose cancer earlier, increasing the chances that a patient responds to treatment. It can also help to monitor cancer cells that persist in patients after treatment.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct